Skip to main content

22 Result(s)

within H. -G. Mergenthaler Remove this filter

previous disabled Page of 2
and

  1. No Access

    Article

    Intensive consolidation versus oral maintenance therapy in patients 61 years or older with acute myeloid leukemia in first remission: results of second randomization of the AML HD98-B treatment Trial

    R F Schlenk, S Fröhling, F Hartmann, J Th Fischer, A Glasmacher, F del Valle… in Leukemia (2006)

  2. No Access

    Chapter

    Paraneoplasien

    Tumoren können fernab vom Primärtumor oder auch von seinenMetastasen Krankheitserscheinungen hervorrufen, die nicht unmittelbar mit der malignen Erkrankung in Verbindung zu stehen scheinen, aber mit ihr assozi...

    K. Possinger, P. Schmid, U. Rüther… in Kompendium Internistische Onkologie (2006)

  3. No Access

    Article

    Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

    The purpose of our study was (i) to evaluate the impact of all-trans retinoic acid (ATRA) given as adjunct to chemotherapy and (ii) to compare second consolidation vs maintenance therapy in elderly patients with ...

    R F Schlenk, S Fröhling, F Hartmann, J Th Fischer, A Glasmacher, F del Valle… in Leukemia (2004)

  4. No Access

    Article

    Further evidence for oxidant-induced vascular endothelial growth factor up-regulation in the bronchoalveolar lavage fluid of lung cancer patients undergoing radio-chemotherapy

    Background: Vascular endothelial growth factor (VEGF) is a potent inducer of physiological and neoplastic blood vessel growth. Moreover, in vitro studies have demonstrated that VEGF can be up-regulated by condit...

    T. Beinert, D. Binder, C. Oehm, S. Ziemer… in Journal of Cancer Research and Clinical On… (2000)

  5. No Access

    Article

    Eosinophilia during fludarabine treatment of chronic lymphocytic leukemia

     Although eosinophilia has been reported as a side effect of purine analogues, there is no report on fludarabine-induced eosinophilia in chronic lymphocytic leukemia (CLL). During chemotherapy with fludarabine...

    O. Sezer, P. Schmid, M. Hallek, M. Schweigert, T. Beinert… in Annals of Hematology (1999)

  6. No Access

    Article

    Fortschritte in der zytostatischen und supportiven Therapie des Pankreaskarzinoms

    D. Lüftner, M. Schweigert, C. Rothermundt, H.-G. Mergenthaler, K. Possinger in Der Onkologe (1999)

  7. No Access

    Article

    Chronische Schmerzen bei Herpes Zoster

    Der Zostererkrankung liegt eine Entzündung des Spinalganglions bzw. der Ganglien entsprechend befallener Hirnnerven zugrunde. Ursache ist die Reaktivierung einer latenten Infektion mit dem neurotropen Varizell...

    H.-G. Mergenthaler, T. Beinert in Der Internist (1999)

  8. No Access

    Article

    Gemcitabine for palliative treatment in metastatic breast cancer

    Gemcitabine is one of the recently developed drugs with a high efficacy in various malignant tumours and a mild toxicity profile. As monochemotherapy in metastatic breast cancer, gemcitabine yielded response ...

    D. Lüftner, B. Flath, C. Akrivakis… in Journal of Cancer Research and Clinical On… (1998)

  9. No Access

    Article

    Paraneoplastische Syndrome

    H.-G. Mergenthaler, T. Beinert, K. Possinger in Der Urologe A (1998)

  10. No Access

    Article

    Paraneoplastische Syndrome

    H.-G. Mergenthaler, T. Beinert, K. Possinger in Der Internist (1998)

  11. No Access

    Article

    Paraneoplastische Syndrome II

    H.-G. Mergenthaler, T. Beinert, K. Possinger in Der Onkologe (1997)

  12. No Access

    Article

    Paraneoplastische Syndrome I

    Maligne Tumore können fernab vom Tumor oder seiner Metastasen Krankheitserscheinungen hervorrufen, die nicht unmittelbar mit der bösartigen Geschwulsterkrankung in Verbindung zu stehen scheinen, aber mit ihr a...

    H.-G. Mergenthaler, T. Beinert, K. Possinger in Der Onkologe (1997)

  13. No Access

    Article

    Dysproportionaler Riesenwuchs, Flammennävi, Hämangiome, Varizen und Erstdiagnose einer monoklonalen Gammopathie

    T. Beinert, C. Schmidt-Kalwa, H.-G. Mergenthaler, M. Fleischhacker… in Der Onkologe (1997)

  14. No Access

    Article

    Molekulargenetischer Nachweis minimal-residueller Erkrankungen in der Hämatologie und Onkologie

    B. Flath, K. Akrivakis, T. Beinert, H.-G. Mergenthaler, K. Possinger in Der Onkologe (1997)

  15. No Access

    Article

    Dokumentationsprogramme in der Onkologie – Oncodoc

    Diana Lüftner, H.-G. Mergenthaler, A. Helle, G. Dingeldein, T. Beinert… in Der Onkologe (1997)

  16. No Access

    Article

    Myelopoiesis in vitro is suppressed by hepatitis A virus

    Perturbations of hematopoietic regulation ranging from transient granulocytopenia to rare cases of bone marrow failure are associated with infections due to hepatitis A virus (HAV). In an attempt to elucidate ...

    F. W. Busch, A. Kunst, B. Flehmig, H. -G. Mergenthaler, G. Pawelec… in Annals of Hematology (1992)

  17. Article

    Abstract

    Ch. Mache, Ch. Urban, H. Sauer, G. Brandesky, H. Meßner… in Annals of Hematology (1992)

    Download PDF (18571 KB)

  18. No Access

    Article

    In vitro hemopoiesis in human micro long-term bone marrow cultures recharged with either allogeneic, T-cell-depleted allogeneic, or syngeneic bone marrow cells

    The production of granulocyte-macrophage colony-forming cells (GM-CFC) and the proliferation period in human long-term bone marrow cultures are inferior to murine cultures. There is also evidence that recharge...

    H. -G. Mergenthaler, P. Dörmer in Blut (1990)

  19. No Access

    Article

    Multiple brown tumors in a patient with nutritional secondary hyperparathyroidism

    For years, brown tumors have been considered to be a characteristic of primary hyperparathyroidism. However, since 1963 several reports indicate the incidence of brown tumors in patients with renal secondary h...

    H.-G. Mergenthaler, M. Fink, H. Sauer, R. Bartl, W. Wilmanns in Klinische Wochenschrift (1989)

  20. No Access

    Article

    Comparative in vitro toxicity of mitoxanatrone and adriamycin in human granulocyte-macrophage progenitor cells

    Mitoxantrone (MIT) has recently been introduced into cancer therapy as a possible substitute for the structurally related drug, adriamycin (ADR), because it causes less cardiotoxicity and fewer gastrointestina...

    H.-G. Mergenthaler, P. Brühl, G. Ehninger… in Cancer Chemotherapy and Pharmacology (1987)

previous disabled Page of 2